Cost-Effectiveness Analysis of Abiraterone in Patients with Metastatic, Castration-Resistant, Prostate Cancer with Progression after Receiving Chemotherapy with Docetaxel, Compared with Receiving only Palliative Support- The Perspective of ...
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1615
https://www.valueinhealthjournal.com/article/S1098-3015(16)01683-1/fulltext
Title :
Cost-Effectiveness Analysis of Abiraterone in Patients with Metastatic, Castration-Resistant, Prostate Cancer with Progression after Receiving Chemotherapy with Docetaxel, Compared with Receiving only Palliative Support- The Perspective of ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01683-1&doi=10.1016/j.jval.2016.03.1615
First page :
A154
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
338